Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
Holding DRMA?
Track your performance easily

Dermata Therapeutics (DRMA) Stock Investors

111 Followers
Based on 761,625 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DRMA
On average, investors allocate 0.00% of their portfolios to DRMA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 761,625 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DRMA

1.9%
Last 7
Days
10.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DRMA, out of 761,625 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DRMA Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$1.70
Reduced
0.00%
$1.74
Based on the activity of 14,587 investors who made their portfolios public
The table shows changes in DRMA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DRMA Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Devon Energy
4.83%
-1.56%
+0.60%
25.41B
Energy
Riot Platforms
4.89%
-0.58%
-0.98%
2.79B
Financial
Coinbase Global
6.59%
-0.63%
-1.13%
50.74B
Financial
DraftKings
5.40%
-1.75%
-2.08%
33.08B
Consumer Cyclical
XPeng, Inc. ADR
5.53%
-1.67%
-1.87%
10.19B
Consumer Cyclical
Viking Therapeutics
5.02%
-1.12%
-0.37%
7.16B
Healthcare
Marathon Digital Holdings
5.42%
-0.64%
-1.29%
5.30B
Financial
Plug Power
5.17%
-0.38%
-2.14%
1.79B
Industrials
APA
4.93%
-1.72%
-5.03%
9.22B
Energy
PDD Holdings
5.13%
-1.58%
-0.16%
171.69B
Consumer Cyclical
Based on the activity of 761,625 active portfolios
Open your Smart Portfolio

DRMA Investor Analysis

DRMA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
27.3%
of DRMA holders
are under 35
Average Segment Performance
Average P/E Ratio22.57
Beta8.36
Dividend Yield7.25%
DRMA investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
27.3%
of DRMA holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.55
Beta14.74
Dividend Yield4.98%
DRMA investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
45.5%
of DRMA holders
are over 55
Average Segment Performance
Average P/E Ratio22.03
Beta7.17
Dividend Yield5.85%
Overview of age group and performance of DRMA stock investors
See who invests in DRMA according to age group and performance.

FAQ

How many retail Investors hold DRMA?
<0.1% of TipRanks' retail investors hold DRMA in their portfolios.
    What is DRMA Investor Sentiment?
    DRMA’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DRMA in the last 7 days?
      ▼ 1.9% of TipRanks' retail investors changed their holding of DRMA in the last 7 days.
        What percentage of retail investors changed their holding of DRMA in the last 30 days?
        ▼ 10.4% of TipRanks' retail investors changed their holding of DRMA in the last 30 days.
          What is the average age of retail investors who hold DRMA?
          The average age of DRMA Holders is over 55.
            What other stocks have DRMA investors also bought?
            DRMA Investors also bought DVN, RIOT, COIN, DKNG, XPEV, VKTX, MARA, PLUG, APA, PDD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AAgilent
              ALKSAlkermes
              ALNYAlnylam Pharma
              AZNAstraZeneca
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis